Scopoderm
Scopoderm is a medicated patch that prevents motion sickness and its symptoms like nausea, vomiting, and dizziness when traveling.
Form
depotlaastari
Strength
1 mg / 72 tuntia
Active Ingredient
Scopolamine
Manufacturer
Baxter Oy
How to Use
Dosage
One patch at a time.
Method
Apply one patch to clean, dry, hairless skin behind your ear about 5-6 hours before your journey. Wash your hands thoroughly after applying and removing the patch.
Important
Use only one patch at a time. One patch provides protection for up to 3 days.
Possible Side Effects
COMMON
- •Dry mouth.
- •Drowsiness, dizziness.
- •Blurred (near) vision and dilated pupils (sometimes in only one eye).
- •Difficulty focusing on near or far objects.
- •Eyelid irritation.
- •Skin irritation.
RARE
- •Changes in vision and increased pressure in the eye (possible signs of glaucoma).
- •Difficulty urinating.
- •Memory or concentration problems, restlessness, confusion, or hallucinations.
- •Rash.
- •Application site reactions, such as itching, redness, and burning.
- •Restlessness, coordination problems, and headache.
Important Warnings
- Do not use if you are allergic to scopolamine or have glaucoma (a serious eye condition).
- Talk to your doctor if you have stomach, bowel, or urination problems, liver or kidney issues, or if you are over 65 years old.
- Tell your doctor if you have eye pain, blurred vision, or epilepsy.
- If you feel confused or see things that are not there (hallucinations), remove the patch immediately and contact a doctor.
- Side effects can occur up to 24 hours after the patch has been removed.
Show 4 more warnings
- Remove the patch before medical imaging tests (like MRI scans).
- Not for children under 10 years old.
- Avoid alcohol while using this medicine.
- This medicine can cause drowsiness, confusion, and vision problems that may affect your ability to drive or use machines.
Use in Elderly Patients
Category D
Avoid use in older adults. Anticholinergic. Consider potential adverse effects, such as tachycardia, confusion and cognitive impairment. Reduces the effectiveness of drugs for Alzheimer’s disease. (updated 20.5.2024)